Hipgnosis Songs Fund Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was USD 200.38 million compared to USD 160.67 million a year ago. Revenue was USD 168.35 million compared to USD 138.31 million a year ago.

Net loss was USD 19.44 million compared to net income of USD 38.94 million a year ago. Basic loss per share from continuing operations was USD 0.0165 compared to basic earnings per share from continuing operations of USD 0.0472 a year ago. Diluted loss per share from continuing operations was USD 0.0165 compared to diluted earnings per share from continuing operations of USD 0.0472 a year ago.